A Food and
Drug Administration advisory committee voted Thursday in favor of an investigational anti-obesity drug, putting it a step closer to winning the agency's approval.The committee voted 18-4, with one abstention, in favor of approving lorcaserin, ...
[
Published May 11 2012 by Channel4000
]